Dilraj Grewal, M.D.
Artificial Intelligence
Biomarkers
Clinical Trials
Dilraj Grewal, MD specializes in the medical and surgical management of patients with complex Vitreoretinal pathology and Uveitis and is a Director of Grading at the Duke Reading Center. His research focus is on 1) Novel Retinal Imaging endpoints in Alzheimer’s and other neurodegenerative diseases 2) Leveraging the use of artificial intelligence to create risk stratification models based on retinal imaging 3) Modeling longitudinal rates of change in retinal imaging in Alzheimer’s and other neurodegenerative diseases to establish potential anatomical endpoints to incorporate into clinical trials.